Learning new information is a lifelong process. Certainly, you do a lot of it when you’re a student, but your daily life requires you to pick up new knowledge and skills. You find out about new ...

AI search is reshaping ecommerce by connecting customer intent with product discovery. This guide shows IT leaders and decision-makers how to optimize structured data, feeds, and content for AI ...

The statewide science assessment scores shared by the Minnesota Department of Education on Wednesday were drastically lower than past years — albeit with new standards.

I tested the new fast charging speeds on all four new iPhone, including the iPhone 17, iPhone 17 Pro, iPhone 17 Pro Max and iPhone Air. Here's how long each takes to charge, and how it compares to the ...

If 2022 was the year OpenAI knocked our world off course with the launch of ChatGPT, 2025 will be remembered for the frenzied embrace of AI as the solution to everything. And, yes, this includes ...

The first tests of the Qualcomm Snapdragon X2 Elite Extreme reveal massive performance improvements over last-generation chips from Qualcomm, Intel and AMD.

Comparing the Aventon Aventure 3 with Walmart’s Magicycle Ocelot Pro shows why spending more on a trusted e-bike brand pays off in safety, quality, and long-term value.

It is hard to get excited after looking at Merit Medical Systems' (NASDAQ:MMSI) recent performance, when its stock ...

Is artificial intelligence (AI) an emerging rival to the familiar decades-old excuse by cheaters that “the dog ate my homework?” New research published in the science journal Nature shows that ...

Canada’s financial regulator and the Insurance Bureau of Canada (IBC) are stepping up pressure for a national earthquake resolution, announcing a joint tabletop exercise this fall to model the capital ...

Lofty clocks, lots of cores, AI horsepower to spare, and a rebuilt GPU: The new Snapdragon X2 Elite Extreme chip looks like a pace-setter in the laptop-CPU race. Here's how it shapes up in early tests ...

The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma showed an advantage to dupilumab (Dupixent) over ...